Surface proteins from Lactobacillus kefir antagonize invitro cytotoxic effect of Clostridium difficile toxins

Anaerobe

Volumn 18, Issue 1, 2012, Pages 135-142

  Carasi, Paula ^a   Trejo, Fernando M ^b   Pérez, Pablo F ^a,b   De Antoni, Graciela L ^b   Serradell, María de los Angeles ^a  

^a FACULTAD DE CIENCIAS EXACTAS   (Argentina)

^b CENTRO DE INVESTIGACIÓN Y DESARROLLO EN CRIOTECNOLOGÍA DE ALIMENTOS CIDCA   (Argentina)

Author keywords

Bacterial toxins; Clostridium difficile; Lactobacillus kefir; S layer protein

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CLOSTRIDIUM TOXIN; F ACTIN; KEFIR; MEMBRANE PROTEIN; PROBIOTIC AGENT; PROTEINASE INHIBITOR; TOXIN ANTIBODY;

ARTICLE; BACTERIUM ISOLATE; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG PROTEIN BINDING; EUKARYOTIC CELL; HEAT TREATMENT; HUMAN; HUMAN CELL; IN VITRO STUDY; LACTOBACILLUS; LACTOBACILLUS KEFIR; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; VERO CELL;

ANIMALS; ANTIBIOSIS; BACTERIAL TOXINS; CELL LINE; CERCOPITHECUS AETHIOPS; CLOSTRIDIUM DIFFICILE; LACTOBACILLUS; MEMBRANE GLYCOPROTEINS; PROTEIN BINDING;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE; EUKARYOTA; LACTOBACILLUS KEFIRI;

EID: 84856756985     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2011.11.002     Document Type: Article

References (48)

1. Limaye A.P., Turgeon D.K., Cookson B.T., Fritsche T.R. Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile. JClin Microbiol 2000, 38:696-697.
2. Schirmer J., Aktories K. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins. Biochim Biophys Acta 2004, 1673:66-74.
3. Jank T., Giesemann T., Aktories K. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 2007, 17:15R-22R.
4. Castagliuolo I., Keates A.C., Wang C.C., Pasha A., Valenick L., Kelly C.P., et al. Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells. JImmunol 1998, 160:6039-6045.
5. Servin A. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 2004, 28:405-440.
6. Corthésy B., Gaskins H.R., Mercenier A. Cross-talk between probiotic bacteria and the host immune system. JNutr 2007, 137:781S-790S.
7. McFarland L.V. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhoea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006, 101:812-822.
8. Castagliuolo I., Riegler M.F., Valenick L., LaMont J.T., Pothoulakis C. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun 1999, 67:302-307.
9. Chen X., Kokkotou E.G., Mustafa N., Bhaskar K.R., Sougioultzis S., Pothoulakis C., et al. Saccharomyces boulardii inhibits ERK1/2 mitogen activated protein kinase activation both invitro and invivo and protects against Clostridium difficile toxin A-induced enteritis. JBiol Chem 2006, 281:24449-24454.
10. Trejo F.M., Minnaard J., érez P.F.P., De Antoni G.L. Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants. Anaerobe 2006, 12:186-193.
11. Trejo F.M., Pérez P.F., De Antoni G.L. Co-culture with potentially probiotic microorganisms antagonizes virulence factors of Clostridium difficile invitro. Antonie Van Leeuwenhoek 2010, 98:19-29.
12. Farnworth E. Kefir - a complex probiotic. Food Sci Technol Bull 2005, 2:1-17.
13. Lebeer S., Vanderleyden J., De Keersmaecker S.C.J. Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev 2008, 72:728-764.
14. Wang B., Wei H., Yuan J., Li Q., Li Y., Li N., et al. Identification of surface protein from Lactobacillus reuteri JCM1081 that adheres to porcin gastric mucin and human enterocyte-like HT-29 cells. Curr Microbiol 2008, 57:33-38.
15. Sánchez B., Arias S., Chaignepain S., Denayrolles M., Shmitter J.M., Bressollier P., et al. Identification of surface proteins involved in the adhesion of a probiotic Bacillus cereus strain to mucin and fibronectin. Microbiology 2009, 155:1708-1716.
16. Kleerebezem M., Hols P., Bernard E., Rolain T., Zhou M., Siezen R.J., et al. Theextracellular biology of lactobacilli. FEMS Microbiol Rev 2010, 34:199-230.
17. Mastromarino P., Cacciotti F., Masci A., Mosca L. Antiviral activity of Lactobacillus brevis towards herpes simplex virus type 2: role of cell wall associated components. Anaerobe 2011, 17:334-336.
18. Sára M., Sleytr U.B. S-layer proteins. JBacteriol 2000, 182:859-868.
19. Avall-Jääskeläinen S., Palva A. Lactobacillus surface layers and their applications. FEMS Microbiol Rev 2005, 29:511-529.
20. Antikainen J., Antón L., Sillanpaa J., Coronen T.K. Domains in the S-layer protein CbsA of Lactobacillus crispatus involved in adherence to collagens, laminin and lipoteichoic acids and self-assembly. Mol Microbiol 2002, 2:381-394.
21. De Leeuw E., Li X., Lu W. Binding characteristics of the Lactobacillus brevis ATCC 8287 surface layer to extracellular matrix. FEMS Microbiol Lett 2006, 260:210-215.
22. Konstantinov S.R., Smidt H., de Vos W.M., Bruijns S.C., Singh S.K., Valence F., et al. Slayer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci 2008, 105:19474-19479.
23. Golowczyc M., Mobili P., Garrote G.L., Serradell M.A., Abraham A.G., De Antoni G.L. Interaction between Lactobacillus kefir and Saccharomyces lipolytica isolated from kefir grains: evidence for lectin-like activity of bacterial surface proteins. JDairy Res 2009, 76:111-116.
24. Horie M., Ishiyama A., Fujihira-Ueki Y., Sillanpaa J., Korhonen T.K., Toba T. Inhibition of the adherence of Escherichia coli strains to basement membrane by Lactobacillus crispatus expressing an S-layer. JAppl Microbiol 2002, 92:396-403.
25. Johnson-Henry K.C., Hagen K.E., Gordonpour M., Tompkins T.A., Sherman P.M. Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorragic Escherichia coli O157:H7 adhesion epithelial cells. Cell Microbiol 2007, 9:356-367.
26. Prado-Acosta M., Ruzal S.M., Allievi M.C., Palomino M.M., Sanchez Rivas C. Synergistic effects of the Lactobacillus acidophilus surface layer and nisin on bacterial growth. Appl Environ Microbiol 2010, 76:974-977.
27. Li P., Yin Y., Yu Q., Yiang Q. Lactobacillus acidophilus S-layer protein-mediated inhibition of Salmonella-induced apoptosis in Caco-2 cells. Biochim Biophys Res Commun 2011, 409:142-147.
28. Garrote G.L., Delfederico L., Bibiloni R., Abraham A.G., Pérez P.F., Semorile L., et al. Lactobacillus isolated from kefir grains: evidence of the presence of S-layer proteins. JDairy Res 2004, 71:222-230.
29. Mobili P., Serradell M.A., Trejo S., Avilés-Puigvert X., Abraham A.G., De Antoni G.L. Heterogeneity of S-layer proteins from aggregating and non-aggregating Lactobacillus kefir strains. Antonie Van Leeuwenhoek 2009, 95:363-372.
30. Mobili P., Londero A., María T.M.R., Eusébio M.E.S., De Antoni G.L., Fausto R., et al. Characterization of S-layer proteins of Lactobacillus by FTIR spectroscopy and differential scanning calorimetry. Vib Spectrosc 2009, 50:68-77.
31. Golowczyc M., Mobili P., Garrote G.L., Abraham A.G., De Antoni G.L. Protective action of Lactobacillus kefir carrying S-layer protein against Salmonella enterica serovar enteritidis. Int J Food Microbiol 2007, 118:264-273.
32. Garrote G.L., Abraham A.G., De Antoni G.L. Chemical and microbiological characterisation of kefir grains. JDairy Res 2001, 68:639-652.
33. Bradford M. Arapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
34. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
35. Sullivan N.M., Pellett S., Wilkins T.D. Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun 1982, 35:1032-1040.
36. Minnaard J., Humen M., Pérez P.F. Effect of Bacillus cereus exocellular factors on human intestinal epithelial cells. JFood Prot 2001, 64:1535-1541.
37. Minnaard J., Lievin-Le Moal V., Coconnier M.H., Servin A., Pérez P.F. Disassembly of F-actin cytoskeleton after interaction of Bacillus cereus with fully differentiated human intestinal Caco-2 cells. Infect Immun 2004, 72:3106-3112.
38. Hickson M., D'Souza A.L., Muthu N., Rogers T.R., Want S., et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007, 335(7610):80.
39. Gao X.W., Mubasher M., Fang C.Y., Reifer C., Miller L.E. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhoea and Clostridium difficile-associated diarrhoea prophylaxis in adult patients. Am J Gastroenterol 2010, 105:1636-1641.
40. Banerjee P., Merkel G.J., Bhunia A.K. Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog 2009, 1:8.
41. Garrote G.L., Abraham A.G., De Antoni G.L. Inhibitory power of kefir: the role of organic acids. JFood Prot 2000, 63:364-369.
42. Londero A., Quinta R., Abraham A.G., Sereno R., De Antoni G., Garrote G.L. Inhibitory activity of cheese whey fermented with kefir grains. JFood Prot 2011, 74:94-100.
43. Bekar O., Yilmaz Y., Gulten M. Kefir improves the efficacy and tolerability oftriple therapy in eradicating Helicobacter pylori. JMed Food 2011, 14:344-347.
44. Medrano M., Pérez P.F., Abraham A.G. Kefiran antagonizes cytopathic effects of Bacillus cereus extracellular factors. Int J Food Microbiol 2008, 122:1-7.
45. Medrano M., Hamet M.F., Abraham A.G., Pérez P.F. Kefiran protects Caco-2 cells from cytopathic effects induced by Bacillus cereus infection. Antonie Van Leeuwenhoek 2009, 96:505-513.
46. Hugo A.A., Kakisu E., De Antoni G.L., Pérez P.F. Lactobacilli antagonize biological effects of enterohaemorrhagic Escherichia coli invitro. Lett Appl Microbiol 2008, 46:613-619.
47. Sleytr U.B., Beveridge T.J. Bacterial S-layers. Trends Microbiol 1999, 7:253-260.
48. Schuster B., Sleytr U.B. Composite S-layer lipid structures. JStruct Biol 2009, 168:207-216.